Czech Republic Enteral Nutrition Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Nasogastric, Nasoenteral, Sipping, and Others)
The Czech Republic enteral nutrition market size is projected to reach US$ 86.38 million by 2031 from US$ 56.42 million in 2023; the market is estimated to register a CAGR of 5.5% during 2023–2031.
Enteral nutrition, or "tube feeding," provides nutrition directly into the gastrointestinal (GI) tract using a feeding tube placed in the stomach or small intestine. Enteral nutrition consists of a liquid food mixture containing all essential nutrients, such as proteins, carbohydrates, fats, vitamins, and minerals. Formulas can be ready-to-feed liquids, powdered or concentrated mixtures, or blended foods. For infants, human breast milk or infant formula can also be considered EN when given through a feeding tube.
General or standard nutrition formulas may not be precise in providing patients with the quantities of nutrients required for the body to function correctly. Therefore, doctors prescribe nutrition products specific to diseases. Renal formulas are more calorically dense and contain lower concentrations of phosphorous, potassium, and magnesium than standard formulas. Similarly, pulmonary formulas feature less carbohydrate content than standard formulas. Pharmaceutical companies provide enteral nutrition with tailored constituents (patient-specific) to meet individual patient needs. For example, Impact (offered by Nestle) is a clinically proven nutritional solution for managing primary elective surgery patients to reduce postoperative complications and length of hospital stays. The increasing prevalence of diseases like diabetes, kidney failure, and cancer leads to higher demand for disease-specific formulas in the Czech Republic.
The growth of home enteral nutrition is a noteworthy factor contributing to the expansion of the Czech Republic enteral nutrition market size. Home enteral nutrition allows patients to continue their nutritional therapy from the comfort of their homes, reducing hospital stays and minimizing healthcare costs. The Czech healthcare system places more emphasis on home care, which reduces the burden on hospital infrastructure, creating a demand for home enteral nutrition. Technological advancements that make at-home feeding more accessible and effective helps favoring the home enteral nutrition. For example, portable feeding pumps and smaller, easier-to-use feeding tubes enable patients to receive nutrition at home without the need for constant medical supervision. The convenience and comfort of receiving treatment at home are expected to make HEN a desirable option for many patients and their families.
Product Type-Based Insights
The Czech Republic enteral nutrition market, based on type, is segmented into nasogastric, nasoenteral, sipping, and others. The nasogastric segment held the largest share in the Czech Republic enteral nutrition market in 2023, and it is expected to register the highest CAGR during 2023–2031. Nasogastric feeding involves the insertion of a small tube into the stomach through the nose, offering a simple, cost-effective solution for providing nutrition to patients facing swallowing difficulties, neurological disorders, or severe conditions that impair oral intake. Nasogastric feeding helps patients get enough nutrition to recover from illness. Nasogastric feeding is commonly prescribed for patients who require short-term feeding support.
The demand for nasogastric feeding in the Czech Republic is driven by the increasing incidence of neurological disorders such as stroke, Parkinson's disease, and other conditions that affect swallowing. Additionally, the aging population in the country is contributing to the rise in the number of patients who require nutritional support, particularly after surgeries or in the management of chronic diseases. Healthcare infrastructure improvements and the availability of advanced, safer NG feeding tube systems are also encouraging the adoption of nasogastric enteral feeding.
The Organisation for Economic Co-operation and Development, International Society of Aesthetic Plastic Surgery, and World Health Organization are among the primary and secondary sources referred to while preparing the Czech Republic enteral nutrition market report.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Czech Republic Enteral Nutrition Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Czech Republic Enteral Nutrition Market – Key Market Dynamics
5.1 Czech Republic Enteral Nutrition Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Chronic Diseases
5.2.2 Rising Aging Population
5.3 Market Restraints
5.3.1 High Cost of Enteral Nutrition
5.4 Market Opportunities
5.4.1 Growth of Home Enteral Nutrition
5.5 Future Trends
5.5.1 Personalized Enteral Nutrition Therapy
5.6 Impact of Drivers and Restraints:
6. Czech Republic Enteral Nutrition Market Analysis
6.1 Czech Republic Enteral Nutrition Market Revenue (US$ Million), 2021–2031
6.2 Czech Republic Enteral Nutrition Market Forecast and Analysis
6.3 Czech Republic Enteral and Parenteral Nutrition Market Value (%)
7. Czech Republic Enteral Nutrition Market Analysis – by Product Type
7.1 Nasogastric
7.1.1 Overview
7.1.2 Nasogastric: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.1.3 Standard
7.1.3.1 Overview
7.1.3.2 Standard: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.1.4 Disease Specific
7.1.4.1 Overview
7.1.4.2 Disease Specific: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Nasoenteral
7.2.1 Overview
7.2.2 Nasoenteral: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Sipping
7.3.1 Overview
7.3.2 Sipping: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8. Czech Republic Enteral Nutrition Market – Country Analysis
8.1 Europe
8.1.1 Czech Republic Enteral Nutrition Market
8.1.1.1 Czech Republic Enteral Nutrition Market Revenue and Forecast and Analysis – by Country
8.1.1.2 Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.1.2.1 Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Product Type
8.1.1.2.2 Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.1.2.3 Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Standard By Calories
8.1.1.2.4 Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Isocaloric
8.1.1.2.5 Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Hypercaloric
8.1.1.2.6 Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Standard By Type
8.1.1.2.7 Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Standard By End user
9. Company Profiles
9.1 Nestle SA
9.1.1 Key Facts
9.1.2 Business Description
9.1.3 Products and Services
9.1.4 Financial Overview
9.1.5 SWOT Analysis
9.1.6 Key Developments
9.2 Danone SA
9.2.1 Key Facts
9.2.2 Business Description
9.2.3 Products and Services
9.2.4 Financial Overview
9.2.5 SWOT Analysis
9.2.6 Key Developments
9.3 Abbott Laboratories
9.3.1 Key Facts
9.3.2 Business Description
9.3.3 Products and Services
9.3.4 Financial Overview
9.3.5 SWOT Analysis
9.3.6 Key Developments
9.4 Royal FrieslandCampina NV
9.4.1 Key Facts
9.4.2 Business Description
9.4.3 Products and Services
9.4.4 Financial Overview
9.4.5 SWOT Analysis
9.4.6 Key Developments
9.5 Fresenius SE & Co KGaA
9.5.1 Key Facts
9.5.2 Business Description
9.5.3 Products and Services
9.5.4 Financial Overview
9.5.5 SWOT Analysis
9.5.6 Key Developments
9.6 B Braun SE
9.6.1 Key Facts
9.6.2 Business Description
9.6.3 Products and Services
9.6.4 Financial Overview
9.6.5 SWOT Analysis
9.6.6 Key Developments
9.7 Reckitt Benckiser Group Plc
9.7.1 Key Facts
9.7.2 Business Description
9.7.3 Products and Services
9.7.4 Financial Overview
9.7.5 SWOT Analysis
9.7.6 Key Developments
9.8 Kate Farms Inc
9.8.1 Key Facts
9.8.2 Business Description
9.8.3 Products and Services
9.8.4 Financial Overview
9.8.5 SWOT Analysis
9.8.6 Key Developments
9.9 Dr Schar AG
9.9.1 Key Facts
9.9.2 Business Description
9.9.3 Products and Services
9.9.4 Financial Overview
9.9.5 SWOT Analysis
9.9.6 Key Developments
9.10 Fonterra Co-Operative Group Ltd
9.10.1 Key Facts
9.10.2 Business Description
9.10.3 Products and Services
9.10.4 Financial Overview
9.10.5 SWOT Analysis
9.10.6 Key Developments
9.11 Perrigo Co Plc
9.11.1 Key Facts
9.11.2 Business Description
9.11.3 Products and Services
9.11.4 Financial Overview
9.11.5 SWOT Analysis
9.11.6 Key Developments
9.12 Arla Foods amba
9.12.1 Key Facts
9.12.2 Business Description
9.12.3 Products and Services
9.12.4 Financial Overview
9.12.5 SWOT Analysis
9.12.6 Key Developments
9.13 Charing Cross Scientific AS
9.13.1 Key Facts
9.13.2 Business Description
9.13.3 Products and Services
9.13.4 Financial Overview
9.13.5 SWOT Analysis
9.13.6 Key Developments
9.14 Bexen Medical
9.14.1 Key Facts
9.14.2 Business Description
9.14.3 Products and Services
9.14.4 Financial Overview
9.14.5 SWOT Analysis
9.14.6 Key Developments
10. Appendix
10.1 About The Insight Partners
10.2 Glossary of Terms
List of Tables
Table 1. Czech Republic Enteral Nutrition Market Segmentation
Table 2. Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 4. Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Country
Table 5. Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 6. Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 7. Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 8. Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 9. Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 10. Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 11. Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End user
Table 12. Glossary of Terms, Czech Republic Enteral Nutrition Market
List of Figures
Figure 1. Czech Republic Enteral Nutrition Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Czech Republic Enteral Nutrition Market Revenue (US$ Million), 2021–2031
Figure 5. Czech Republic Enteral Nutrition Market Share (%) – by Product Type, 2023 and 2031
Figure 6. Nasogastric: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Standard: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Disease Specific: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Nasoenteral: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Sipping: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Others: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
- Nestle SA
- Danone SA
- Abbott Laboratories
- Royal FrieslandCampina NV
- Fresenius SE & Co KGaA
- B Braun SE
- Reckitt Benckiser Group Plc
- Kate Farms Inc
- Dr Schar AG
- Fonterra Co-Operative Group Ltd
- Perrigo Co Plc
- Arla Foods amba
- Charing Cross Scientific AS
- Bexen Medical
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Czech Republic enteral nutrition market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Czech Republic enteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.